Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 201–300 of 1,888
A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain
Del-Aguila, J. L., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Fernandez, M. V., Ibanez, L., Bradley, J., Wang, F., Bergmann, K., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0524-x · Cited by 183
Lesca, G., Rudolf, G., Labalme, A., Hirsch, E., Arzimanoglou, A., Genton, P., Motte, J., de Saint Martin, A., Valenti, M., Boulay, C., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03559.x · Cited by 181
“Convergences of molecular abnormalities in autistic brains (Voineagu et al., 2011) and of interaction networks of ASD proteins (Sakai et al.”
BackgroundRNA Protein Interaction in Neurons
Darnell, R. B. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062912-114322 · Cited by 181
“Since Geschwind and colleagues have implicated RBFOX1-mediated splicing defects as contributory to autism (Voineagu et al., 2011), it will be of interest to assess whether the activity-regulated splicing targets identified in mice overlay those associated with human disease.”
BackgroundResultInfluentialAutism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing
Parras, A., Anta, H., Santos-Galindo, M., Swarup, V., Elorza, A., Nieto-González, J. L., Picó, S., Hernández, I. H., Díaz-Hernández, J. I., Belloc, E., et al. (2018) · Nature · doi:10.1038/s41586-018-0423-5 · Cited by 177
Self-citationTong, M., Li, X., Wegener Parfrey, L., Roth, B., Ippoliti, A., Wei, B., Borneman, J., McGovern, D. P. B., Frank, D. N., Li, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080702 · Cited by 177
“In biological networks, modules can correspond to functional subunits such as protein complexes [47] or molecular pathways [48].”
BackgroundSelf-citationQuesnel-Vallières, M., Dargaei, Z., Irimia, M., Gonatopoulos-Pournatzis, T., Ip, J. Y., Wu, M., Sterne-Weiler, T., Nakagawa, S., Woodin, M. A., Blencowe, B. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.033 · Cited by 178
“These and a subsequent study also revealed misregulation of 5%–10% of alternative exons in patients with reduced levels of transcripts encoding members of the Rbfox family of RNA-binding splicing regulators (Voineagu et al., 2011; Weyn-Vanhentenryck et al., 2014).”
BackgroundMethodSelf-citationElevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations
Xu, Z.-X., Kim, G. H., Tan, J.-W., Riso, A. E., Sun, Y., Xu, E. Y., Liao, G.-Y., Xu, H., Lee, S.-H., Do, N.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15530-3 · Cited by 176
Alternative splicing: decoding an expansive regulatory layer
Irimia, M., & Blencowe, B. J. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.03.005 · Cited by 177
“Transcriptome profiling of brain tissue has revealed frequent AS changes linked to the misregulation of RBFOX1 in patients with autism spectrum disorder [27 ].”
BackgroundSelf-citationJohnson, M. R., Behmoaras, J., Bottolo, L., Krishnan, M. L., Pernhorst, K., Santoscoy, P. L. M., Rossetti, T., Speed, D., Srivastava, P. K., Chadeau-Hyam, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7031 · Cited by 177
Griswold, A. J., Ma, D., Cukier, H. N., Nations, L. D., Schmidt, M. A., Chung, R.-H., Jaworski, J. M., Salyakina, D., Konidari, I., Whitehead, P. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds164 · Cited by 175
“Of particular interest among these genes is the splice factor A2BP1 which has not only been associated with autism but regulates the expression of many genes misregulated in post-mortem autism brains (74).”
BackgroundHuman 3D cellular model of hypoxic brain injury of prematurity
Pașca, A. M., Park, J.-Y., Shin, H.-W., Qi, Q., Revah, O., Krasnoff, R., O’Hara, R., Willsey, A. J., Palmer, T. D., & Pașca, S. P. (2019) · Nature Medicine · doi:10.1038/s41591-019-0436-0 · Cited by 174
Kim, I. H., Racz, B., Wang, H., Burianek, L., Weinberg, R., Yasuda, R., Wetsel, W. C., & Soderling, S. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0035-13.2013 · Cited by 172
“Genomic studies of risk factors has led to a developing consensus that these disorders may reflect a signaling network or “pathway” dysfunction (Walsh et al., 2008; International Schizophrenia Consortium et al., 2009; Gilman et al., 2011; Sakai et al., 2011; Voineagu et al., 2011; Casey et al., 2012; Durand et al., 20…”
BackgroundDecreased tryptophan metabolism in patients with autism spectrum disorders
Boccuto, L., Chen, C.-F., Pittman, A. R., Skinner, C. D., McCartney, H. J., Jones, K., Bochner, B. R., Stevenson, R. E., & Schwartz, C. E. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-16 · Cited by 171
“…organization of the fronto-temporal lobes is one of the most consistent neuroanatomical findings in ASD patients [25], and lower expression levels of genes involved in synapses, neurotransmitter transport and neuron projection have been detected in frontal and temporal lobes of ASD brains [38].”
Maternal immune activation in neurodevelopmental disorders
Solek, C. M., Farooqi, N., Verly, M., Lim, T. K., & Ruthazer, E. S. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24612 · Cited by 168
“A larger study using microarray and RNA-seq to assess differential transcription regulation in ASD likewise reported increased expression of many genes associated with immune and inflammatory responses in samples from autistic individuals (Voineagu et al., 2011).”
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
Anand, N., Gorantla, V. R., & Chidambaram, S. B. (2022) · Cells · doi:10.3390/cells12010054 · Cited by 171
The shape of the human language-ready brain
Boeckx, C. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00282 · Cited by 161
“Finally, DLX1 seems to be downregulated in autists (Voineagu et al., 2011).”
BackgroundPoultney, C. S., Goldberg, A. P., Drapeau, E., Kou, Y., Harony-Nicolas, H., Kajiwara, Y., De Rubeis, S., Durand, S., Stevens, C., Rehnström, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.001 · Cited by 169
Genetics of glutamate and its receptors in autism spectrum disorder
Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 170
“The post-mortem studies on idiopathic ASD individuals have revealed that genes involved in activated astrocytes and microglia are upregulated in the cortex of the brain and to a lesser extent in the cerebellum [198, 199].”
BackgroundSingle-cell genomics and regulatory networks for 388 human brains
Emani, P. S., Liu, J. J., Clarke, D., Jensen, M., Warrell, J., Gupta, C., Meng, R., Lee, C. Y., Xu, S., Dursun, C., et al. (2024) · Science · doi:10.1126/science.adi5199 · Cited by 163
Self-citationLuo, R., Sanders, S. J., Tian, Y., Voineagu, I., Huang, N., Chu, S. H., Klei, L., Cai, C., Ou, J., Lowe, J. K., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.011 · Cited by 167
“Autism, also known as autism spectrum disorders (ASDs [MIM 209850]), is a heterogeneous syndrome defined by impairments in three core domains: social interaction, language, and range of interests.1,2 Autism is not viewed in isolation, but rather as one of several entities collectively referred to as ASDs.1 Both family…”
BackgroundInfluentialSelf-citationYoshida, T., Yasumura, M., Uemura, T., Lee, S.-J., Ra, M., Taguchi, R., Iwakura, Y., & Mishina, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2136-11.2011 · Cited by 166
“Recently, rare variants in candidate genes have been reported (Pinto et al., 2010; Gilman et al., 2011; Levy et al., 2011; Sanders et al., 2011; Voineagu et al., 2011).”
BackgroundZhang, Q., Ma, C., Gearing, M., Wang, P. G., Chin, L.-S., & Li, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0524-2 · Cited by 165
The landscape of DNA methylation amid a perfect storm of autism aetiologies
Ciernia, A. V., & LaSalle, J. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.41 · Cited by 165
Brain Transcriptional and Epigenetic Associations with Autism
Ginsberg, M. R., Rubin, R. A., Falcone, T., Ting, A. H., & Natowicz, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044736 · Cited by 164
“The top 300 differentially expressed probes were used to generate a non-redundant gene list and compared with two published differentially expressed autism gene lists in brain [13,28] (Table S6).”
BackgroundMethodResultInfluentialKong, S. W., Collins, C. D., Shimizu-Motohashi, Y., Holm, I. A., Campbell, M. G., Lee, I.-H., Brewster, S. J., Hanson, E., Harris, H. K., Lowe, K. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049475 · Cited by 164
“Prior studies have shown differentially expressed genes and miRNAs in brain [48–52] and blood [15–23] samples from patients with ASD.”
BackgroundUddin, M., Tammimies, K., Pellecchia, G., Alipanahi, B., Hu, P., Wang, Z., Pinto, D., Lau, L., Nalpathamkalam, T., Marshall, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2980 · Cited by 163
Self-citationWang, J., Ma, Z., Carr, S. A., Mertins, P., Zhang, H., Zhang, Z., Chan, D. W., Ellis, M. J. C., Townsend, R. R., Smith, R. D., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060301 · Cited by 160
Autism spectrum disorder: insights into convergent mechanisms from transcriptomics
Quesnel-Vallières, M., Weatheritt, R. J., Cordes, S. P., & Blencowe, B. J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0066-2 · Cited by 162
Self-citationHuman induced pluripotent stem cells for modelling neurodevelopmental disorders
Ardhanareeswaran, K., Mariani, J., Coppola, G., Abyzov, A., & Vaccarino, F. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.45 · Cited by 160
Genomic Perspectives of Transcriptional Regulation in Forebrain Development
Nord, A. S., Pattabiraman, K., Visel, A., & Rubenstein, J. L. R. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.011 · Cited by 152
“…generated by recent attempts to intersect neurodevelopmental transcriptome data with genes linked to autism and schizophrenia is, as of now, more suggestive than conclusive regarding the pathophysiology of these disorders (Parikshak et al., 2013; Voineagu et al., 2011; Willsey et al., 2013).”
InfluentialGenetics of structural and functional brain changes in autism spectrum disorder
Hashem, S., Nisar, S., Bhat, A. A., Yadav, S. K., Azeem, M. W., Bagga, P., Fakhro, K., Reddy, R., Frenneaux, M. P., & Haris, M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00921-3 · Cited by 157
Convergence of Sex Differences and the Neuroimmune System in Autism Spectrum Disorder
McCarthy, M. M., & Wright, C. L. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.004 · Cited by 158
“They landed solidly on the side of the second hypotheses after comparing gene expression in postmortem cortex and finding that gene sets naturally higher in males compared to females were also elevated in males with ASD compared to controls, based on previously published studies (38,39).”
ResultMolecular and network-level mechanisms explaining individual differences in autism spectrum disorder
Buch, A. M., Vértes, P. E., Seidlitz, J., Kim, S. H., Grosenick, L., & Liston, C. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01259-x · Cited by 158
Two gene co-expression modules differentiate psychotics and controls
Chen, C., Cheng, L., Grennan, K., Pibiri, F., Zhang, C., Badner, J. A., Members of the Bipolar Disorder Genome Study (BiGS) Consortium, Gershon, E. S., & Liu, C. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.146 · Cited by 157
Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice
Jung, H., Park, H., Choi, Y., Kang, H., Lee, E., Kweon, H., Roh, J. D., Ellegood, J., Choi, W., Kang, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0208-z · Cited by 157
Kubota, T., Miyake, K., & Hirasawa, T. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-1 · Cited by 157
“A recent comprehensive study confirmed that there were differences between autistic and control brains in the expression levels of genes encoding synaptic proteins and proteins related to inflammation [12].”
BackgroundBirey, F., Li, M.-Y., Gordon, A., Thete, M. V., Valencia, A. M., Revah, O., Pașca, A. M., Geschwind, D. H., & Pașca, S. P. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.11.011 · Cited by 170
Self-citationYang, W., Gao, P., Li, H., Huang, J., Zhang, Y., Ding, H., & Zhang, W. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146919 · Cited by 160
Unusual Processing Generates SPA LncRNAs that Sequester Multiple RNA Binding Proteins
Wu, H., Yin, Q.-F., Luo, Z., Yao, R.-W., Zheng, C.-C., Zhang, J., Xiang, J., Yang, L. C., & Chen, L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.007 · Cited by 169
“Their aberrant localization and expression have been reported to be associated with neurogenetic disorders, such as Amyotrophic Lateral Sclerosis (Lagier-Tourenne et al., 2012; Tollervey et al., 2011) and autism (Voineagu et al., 2011; Weyn-Vanhentenryck et al., 2014).”
BackgroundCanitano, R., & Pallagrosi, M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00069 · Cited by 153
Cakir, B., Tanaka, Y., Kiral, F. R., Xiang, Y., Dagliyan, O., Wang, J., Lee, M., Greaney, A. M., Yang, W. S., duBoulay, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28043-y · Cited by 162
Kozlenkov, A., Roussos, P., Timashpolsky, A., Barbu, M., Rudchenko, S., Bibikova, M., Klotzle, B., Byne, W., Lyddon, R., Di Narzo, A. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt838 · Cited by 154
A Noncoding RNA Antisense to Moesin at 5p14.1 in Autism
Kerin, T., Ramanathan, A., Rivas, K., Grepo, N., Coetzee, G. A., & Campbell, D. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003479 · Cited by 149
“Further, network analysis of microarray data from postmortem ASD brain placed MSN as a central node (29).”
BackgroundResultInfluentialFrom early markers to neuro-developmental mechanisms of autism
Gliga, T., Jones, E. J. H., Bedford, R., Charman, T., & Johnson, M. H. (2014) · Developmental Review · doi:10.1016/j.dr.2014.05.003 · Cited by 150
“However, recent molecular biology findings suggest that large sets of ASD candidate genes contribute to molecular pathways that converge on a few functional networks (Hu, 2012; Voineagu et al., 2011), mainly involved with neuronal transcription regulation and synaptic plasticity (Parikshak et al.”
A quarter century of progress on the early detection and treatment of autism spectrum disorder
Dawson, G., & Bernier, R. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000710 · Cited by 149
“…has provided insight into the biology of autism whereas the elucidation of networks of implicated proteins has suggested that common molecular pathways underlie the phenotypic expression from a multitude of genotypic presentations (Geschwind, 2011; Sakai et al., 2011; Voineagu et al., 2011).”
BackgroundFetit, R., Hillary, R. F., Price, D. J., & Lawrie, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.014 · Cited by 148
Brain region-specific altered expression and association of mitochondria-related genes in autism
Anitha, A., Nakamura, K., Thanseem, I., Yamada, K., Iwayama, Y., Toyota, T., Matsuzaki, H., Miyachi, T., Yamada, S., Tsujii, M., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-12 · Cited by 147
“The differences in the results of our study and other whole genome transcriptomic analyses of autism brain [17,38,39] might be due to the differences in the regions of brain that were analyzed.”
Tang, S., Sun, N., Floris, D. L., Zhang, X., Di Martino, A., & Yeo, B. T. T. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.11.009 · Cited by 144
“In parallel, evidence from genetics and neurobiology suggests that autism results from the combination of multiple factors underlying distinct pathways (21,22).”
BackgroundPhan, B. N., Bohlen, J. F., Davis, B. A., Ye, Z., Chen, H.-Y., Mayfield, B., Sripathy, S. R., Cerceo Page, S., Campbell, M. N., Smith, H. L., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0578-x · Cited by 145
Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics
Wamsley, B., Bicks, L. K., Cheng, Y., Kawaguchi, R., Quintero, D., Grundman, J., Liu, J., Xiao, S., Hawken, N., Margolis, M., et al. (2024) · Science · doi:10.1126/science.adh2602 · Cited by 169
“…neuronal markers and synaptic genes, and an attenuation of the typical patterns of gene expression associated with cortical regional identity ( 6 – 8 These genomic data represent an essential lens through which to understand the cellular and physiological changes occurring in the brains of…”
BackgroundSelf-citationNetworks of Neuronal Genes Affected by Common and Rare Variants in Autism Spectrum Disorders
Ben-David, E., & Shifman, S. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002556 · Cited by 145
“To study how the enrichment of rare and common variants corresponded to this study, we tested the overlap between the neuronal modules obtained in our study and the neuronal module that was previously shown to be differentially expressed between cases and controls [20].”
BackgroundMethodResultInfluentialBlumenthal, I., Ragavendran, A., Erdin, S., Klei, L., Sugathan, A., Guide, J. R., Manavalan, P., Zhou, J. Q., Wheeler, V. C., Levin, J. Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.004 · Cited by 145
“Genes responsible for neuronal development and immune response have emerged as commonly dysregulated in several studies,(21,22) including one analysis of coexpression in postmortem brain, which also found regional differences implicating abnormal patterns of brain development.(23) Finally, there is significant evidenc…”
ResultFunctional roles of alternative splicing factors in human disease
Cieply, B. W., & Carstens, R. P. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1276 · Cited by 175
The role of NrCAM in neural development and disorders—Beyond a simple glue in the brain
Sakurai, T. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.12.002 · Cited by 159
Watson, C. N., Belli, A., & Di Pietro, V. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00364 · Cited by 144
“, 2014) and alternative splicing seen in ASD (Voineagu et al., 2011) as HBII-52 may regulate 5-HT2C receptor mRNA levels (Stamova et al.”
BackgroundInfluentialUnifying immunology with informatics and multiscale biology
Kidd, B. A., Peters, L. A., Schadt, E. E., & Dudley, J. T. (2014) · Nature Immunology · doi:10.1038/ni.2787 · Cited by 144
“This analysis can provide data-defined groups of genes (modules) that offer a new modality for biological interpretability 59,83–85 .”
BackgroundKane, M. J., Angoa-Peréz, M., Briggs, D. I., Sykes, C. E., Francescutti, D. M., Rosenberg, D. R., & Kuhn, D. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048975 · Cited by 143
“Polymorphisms in the gene for tryptophan hydroxylase 2 (TPH2), the initial and rate-limiting enzyme in the synthesis of 5HT, have been associated with ASD and repetitive behaviors [14] in some studies [15,16,17] while others find no such association [18,19,20,21].”
BackgroundIntegrative genomics identifies APOE ε4 effectors in Alzheimer's disease
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A. (2013) · Nature · doi:10.1038/nature12415 · Cited by 171
Retractedde Jong, S., Boks, M. P. M., Fuller, T. F., Strengman, E., Janson, E., de Kovel, C. G. F., Ori, A. P. S., Vi, N., Mulder, F., Blom, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039498 · Cited by 144
“Previous studies find enrichment of disease related SNPs in their co-expression modules of interest, implicating that these modules represent causal effects [58,59].”
BackgroundSelf-citationRecurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications
Wilfert, A. B., Sulovari, A., Turner, T. N., Coe, B. P., & Eichler, E. E. (2017) · Genome Medicine · doi:10.1186/s13073-017-0498-x · Cited by 144
“Such genes have been reported as differentially expressed, for example, in the postmortem brains of patients with ASD [119, 120].”
BackgroundGlial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Henstridge, C. M., Tzioras, M., & Paolicelli, R. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00063 · Cited by 143
Infant siblings and the investigation of autism risk factors
Newschaffer, C. J., Croen, L. A., Fallin, M. D., Hertz-Picciotto, I., Nguyen, D. V., Lee, N. L., Berry, C. A., Farzadegan, H., Hess, H. N., Landa, R. J., et al. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-7 · Cited by 143
“Early brain overgrowth in autism, now documented in two longitudinal brain imaging studies [96,97], also suggests the presence of causal events occurring prior to birth, as does the recent brain transcriptomics report that autism brains lacked a pattern of differential gene expression across frontal and temporal corti…”
BackgroundResultAutism-Associated Promoter Variant in MET Impacts Functional and Structural Brain Networks
Rudie, J. D., Hernandez, L. M., Brown, J. A., Beck-Pancer, D., Colich, N. L., Gorrindo, P., Thompson, P. M., Geschwind, D. H., Bookheimer, S. Y., Levitt, P., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.010 · Cited by 142
“, 2007) and did not display the same temporo-frontal differential expression pattern as control subjects (Voineagu et al., 2011).”
BackgroundSelf-citationAssembloid CRISPR screens reveal impact of disease genes in human neurodevelopment
Meng, X., Yao, D., Imaizumi, K., Chen, X., Kelley, K. W., Reis, N., Thete, M. V., Arjun McKinney, A., Kulkarni, S., Panagiotakos, G., et al. (2023) · Nature · doi:10.1038/s41586-023-06564-w · Cited by 141
Madore, C., Leyrolle, Q., Lacabanne, C., Benmamar-Badel, A., Joffre, C., Nadjar, A., & Layé, S. (2016) · Neural Plasticity · doi:10.1155/2016/3597209 · Cited by 141
“While many studies provide evidence for altered immune responses in patients with ASD [12, 111], recent transcriptome and protein interactome network analyses have revealed a direct link between genes implicated in ASD and immune signaling [112, 113].”
BackgroundDysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder
Nardone, S., Sams, D. S., Zito, A., Reuveni, E., & Elliott, E. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx250 · Cited by 137
“However, only recent transcriptomic (Voineagu et al. 2011) and Magnetic Resonance Imaging (MRI) studies (Robertson et al. 2016) determined the direct implication of GABAergic system in the imbalance of (E/I) neurotransmission.”
BackgroundInfluentialCorominas, R., Yang, X., Lin, G. N., Kang, S., Shen, Y., Ghamsari, L., Broly, M., Rodriguez, M., Tam, S., Wanamaker, S. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms4650 · Cited by 140
“The experimental and computational approaches including gene coexpression 12,13 , functional annotations 14,15 , mouse model phenotypes 16 and protein–protein interactions (PPIs) 3,17,18 were used to search for molecular processes and pathways shared by the ASD risk factors.”
Self-citationIntegrated systems analysis reveals a molecular network underlying autism spectrum disorders
Li, J., Shi, M., Ma, Z., Zhao, S., Euskirchen, G., Ziskin, J., Urban, A., Hallmayer, J., & Snyder, M. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145487 · Cited by 132
Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 153
“Furthermore, transcriptomic studies on the brain of patients with ASD have shown that the most prominent alterations in transcriptomes are related to neuro-immune axis including nuclear factor-kappaB (NF-kB) signaling (Garbett et al. 2008; Voineagu et al. 2011).”
Neocortical neurogenesis and the etiology of autism spectrum disorder
Packer, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.002 · Cited by 138
The immune system and psychiatric disease: a basic science perspective
Bennett, F. C., & Molofsky, A. V. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13334 · Cited by 137
Primary Cilia Signaling Shapes the Development of Interneuronal Connectivity
Guo, J., Otis, J. M., Higginbotham, H., Monckton, C., Cheng, J., Asokan, A., Mykytyn, K., Caspary, T., Stuber, G. D., & Anton, E. S. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.07.010 · Cited by 136
“We therefore examined how disrupted primary cilia signaling affects the formation and function of striatal interneuronal circuitry, dysfunction of which is widely implicated in the pathophysiology of a spectrum of NPDs (Clark et al., 2009; Shepherd, 2013).”
InfluentialIdentification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0223-3 · Cited by 136
“…permutation method that allows us to rank PPI hubs by p value. miRNA Weighted Co-expression Network Analysis miRNA co-expression networks for each brain region, except the cerebellum, at the 6 month time point was constructed separately using the R package WGCNA as described previously 39 .”
Self-citationUpdating the mild encephalitis hypothesis of schizophrenia
Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 156
“, 2011) or molecular pathology from genetic and non-genetic aspects converging to finally relevant pathomechanisms (Voineagu et al., 2011).”
BackgroundDevelopmental regulation of RNA processing by Rbfox proteins
Conboy, J. G. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1398 · Cited by 144
“In a few cases, reduced Rbfox1 mRNA expression has been confirmed in autistic brains, where Rbfox1 behaves as a ‘hub’ in the ASD gene transcriptome network.(71) Reduced Rbfox1 expression has also been reported in failing hearts of patients with DCM.”
BackgroundSarachana, T., & Hu, V. W. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-14 · Cited by 135
“Among the RORA-enriched promoter sites, the site corresponding to ITPR1 was used as a positive control since Itpr1 had been identified as a transcriptional target of Rora in mice [29].”
BackgroundInfluentialGenetic Changes Shaping the Human Brain
Bae, B.-I., Jayaraman, D., & Walsh, C. A. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.035 · Cited by 135
Correspondence between Resting-State Activity and Brain Gene Expression
Wang, G.-Z., Belgard, T. G., Mao, D., Chen, L., Berto, S., Preuss, T. M., Lu, H., Geschwind, D. H., & Konopka, G. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.022 · Cited by 142
Self-citationWong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“Transcriptome analyses of ASD brains also have indicated an upregulation of immune response genes (Garbett et al., 2008; Voineagu et al., 2011; Ziats and Rennert, 2011).”
BackgroundEpigenetic Regulation of UBE3A and Roles in Human Neurodevelopmental Disorders
LaSalle, J. M., Reiter, L. T., & Chamberlain, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.70 · Cited by 129
RNA-binding proteins in neurological development and disease
Prashad, S., & Gopal, P. P. (2020) · RNA Biology · doi:10.1080/15476286.2020.1809186 · Cited by 129
“These human tissue studies also demonstrated reduced levels of RBFOX1 and dysregulation of RBFOX1-dependent alternative splicing in ASD brains [3].”
BackgroundInfluentialPearson, B. L., Simon, J. M., McCoy, E. S., Salazar, G., Fragola, G., & Zylka, M. J. (2016) · Nature Communications · doi:10.1038/ncomms11173 · Cited by 127
Rosen, E. Y., Wexler, E. M., Versano, R., Coppola, G., Gao, F., Winden, K. D., Oldham, M. C., Martens, L. H., Zhou, P., Farese, R. V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.021 · Cited by 128
Self-citationSestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127
Nardone, S., & Elliott, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00329 · Cited by 125
“These findings correlate very well with genome-wide transcriptomic studies that demonstrated an increased expression of microglia and innate immune responserelated genes in the brain of individuals with autism (Voineagu et al., 2011; Gupta et al., 2014).”
BackgroundResultMerner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 143
“…number of protein-protein interaction networks that operate in the same molecular processes, such as those controlling synaptic structure and function (Gilman et al., 2011; Voineagu et al., 2011; O’Roak et al., 2012; EPGP Collaborative et al., 2013; de Rubeis et al., 2014; Krumm et al., 2014).”
BackgroundMendez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P., Erritzoe, D., Howes, O., Lingford-Hughes, A., Murphy, D., & Nutt, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.008 · Cited by 126
“Finally, reduced frontal and temporal cortical expression of mRNA in a network of genes highly expressed in GABA interneurons was observed in two samples of ASD (Voineagu et al., 2011).”
Lazaro, M. T., Taxidis, J., Shuman, T., Bachmutsky, I., Ikrar, T., Santos, R., Marcello, G. M., Mylavarapu, A., Chandra, S., Foreman, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.006 · Cited by 125
Self-citationJin, L., Li, G., Yu, D., Huang, W., Cheng, C., Liao, S., Wu, Q., & Zhang, Y. (2017) · BMC Genomics · doi:10.1186/s12864-017-3507-y · Cited by 136
Dawson, G., Sun, J. M., Davlantis, K. S., Murias, M., Franz, L., Troy, J. D., Simmons, R., Sabatos‐DeVito, M., Durham, R., & Kurtzberg, J. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0474 · Cited by 136
Lipscombe, D., Andrade, A., & Allen, S. E. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.09.018 · Cited by 122
“ute to neurological and psychiatric diseases [35,94–98].”
Yang, W., Gao, P., Ma, G., Huang, J., Wu, Y., Wan, L., Ding, H., & Zhang, W. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117413 · Cited by 123
Costa, V., Aigner, S., Vukcevic, M., Sauter, E., Behr, K., Ebeling, M., Dunkley, T., Friedlein, A., Zoffmann, S., Meyer, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.090 · Cited by 119
“In addition, we observed in both genotypes downregulation of RBFOX1, a splicing factor reduced in brains from idiopathic ASD patients (Figure S3J) (Fogel et al., 2012, Voineagu et al., 2011).”
BackgroundInfluentialRisk factors in autism: Thinking outside the brain
Matelski, L., & Van de Water, J. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.11.003 · Cited by 119
Mor, M., Nardone, S., Sams, D. S., & Elliott, E. (2015) · Molecular Autism · doi:10.1186/s13229-015-0040-1 · Cited by 118
“, using a whole genome transcriptome approach, determined the downregulation of many transcripts encoding synaptic proteins and the overexpression of many transcripts encoding immune system proteins in the frontal cortex of individuals with autism [4].”
MethodGenome‐wide screening for DNA variants associated with reading and language traits
Gialluisi, A., Newbury, D. F., Willcutt, E. G., Olson, R. K., DeFries, J. C., Brandler, W. M., Pennington, B. F., Smith, S. D., Scerri, T. S., Simpson, N. H., et al. (2014) · Genes Brain & Behavior · doi:10.1111/gbb.12158 · Cited by 141
“The homologous gene RBFOX1 has been implicated in several neurodevelopmental disorders, including Rolandic Epilepsy (Lal et al. 2013) and Autism Spectrum Disorder (Voineagu et al. 2011), and is a downstream target of FOXP2, a transcription factor implicated in monogenic speech and language disorders (Ayub et al. 2013).”
BackgroundInfluentialFumagalli, M., Lecca, D., Abbracchio, M. P., & Ceruti, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00941 · Cited by 130
Chen, Y., Huang, W.-C., Sejourne, J., Clipperton-Allen, A. E., & Page, D. T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5272-14.2015 · Cited by 117
“…frontal cortex maturation (Zilbovicius et al., 1995), increased cortex size (Piven et al., 1996; Courchesne, 2002; Carper and Courchesne, 2005), increased neuronal number in the prefrontal cortex (Courchesne et al., 2011), and altered molecular networks (Boylan et al., 2007; Voineagu et al., 2011).”
BackgroundMicrobiota, immunoregulatory old friends and psychiatric disorders
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_15 · Cited by 117
Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTor
Oguro-Ando, A., Rosensweig, C., Herman, E., Nishimura, Y., Werling, D., Bill, B. R., Berg, J. M., Gao, F., Coppola, G., Abrahams, B. S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.124 · Cited by 117
Self-citation
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.